期刊文献+

结节病患者支气管肺泡灌洗液中CD_4^+/CD_8^+的分布研究 被引量:4

Distribution of CD_4^+/CD_8^+ in Bronchoalveolar Lavage Fluid in Sarcoidosis
下载PDF
导出
摘要 目的为了明确支气管肺泡灌洗液(BALF)中淋巴细胞和CD4+/CD8+比值在肺结节病中的诊断意义。方法选取92例经病理诊断的结节病患者,评估其临床参数,并把支气管肺泡灌洗(BAL)作为初诊评估的一部分,检测BALF中细胞类型及淋巴细胞亚群CD4+/CD8+比值。结果对于本研究的结节病患者,CD4+/CD8+比值范围为0.2~14.3,中位值3.3(均值2.5)。仅有20例(25%)结节病患者CD4+/CD8+比值>4,8例患者(10%)CD4+/CD8+比值<1,淋巴细胞增加或减少和CD4+/CD8+比值分布相似。结论经病理确诊的结节病患者BALF中CD4+/CD8+比值分布具有高度变异性。BALF中淋巴细胞亚群对于结节病的诊断敏感性较低。 Objective To identify diagnostic significance of lymphocytes and the ratio of CD+4 to CD+8(CD+4/CD+8 ratio) in bronchoalveolar lavage fluid(BALF) in sarcoidosis.Methods Clinical parameters of 92 patients confirmed with sarcoidosis were tested,and the BAL was also evaluated in the first visit.Cell types and the ratio of CD+4/CD+8 in BALF were tested.Results In these patients,the CD4/CD8 ratio ranged from 0.2 to 14.3,with a median value of 3.3(mean 2.5).The CD4/CD8 ratio was greater than 4 in only 20(25%) patients.8 patients(10%) had a CD4/CD8 ratio less than 1.The distribution of CD4/CD8 ratios was similar to the increase or decrease of BAL lymphocytosis.Conclusion The CD4/CD8 ratio in bronchoalveolar lavage fluid is highly variable in biopsy-proven sarcoidosis.Bronchoalveolar lavage lymphocyte subset determination has low sensitivity for this disease.
出处 《中国全科医学》 CAS CSCD 北大核心 2011年第17期1900-1902,共3页 Chinese General Practice
关键词 结节病 支气管肺泡灌洗液 淋巴细胞亚群 Sarcoidosis Bronchoalveolar lavage fluid Lymphocyte subset
  • 相关文献

参考文献11

  • 1Morgenthau AS,Iannuzzi MC.Recent advances in sarcoidosis[J].Chest,2011,139:174-182.
  • 2Grunewald J,Eklund A.Role of CD+4 T cells in sarcoidosis[J].Proc Am Thorac Soc,2007,15:461-464.
  • 3Agostini C,Trentin L,Zambello R,et al.CD8 alveolitis in sarcoidosis:incidence,phenotypic characteristics,and clinical features[J].Am J Med,1993,95:466-472.
  • 4支气管肺泡灌洗液细胞学检测技术规范(草案)[J].中华结核和呼吸杂志,2002,25(7):390-391. 被引量:202
  • 5Welker L,Jorres RA,Costabel U,et al.Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases[J].Eur Respir J,2004,24:1000-1006.
  • 6姚琴,徐作军,黄慧,田欣伦,刘鸿瑞,许文兵,陈勇,朱元珏,罗慰慈.单项和联合指标在结节病诊断中的预测价值评价[J].中华结核和呼吸杂志,2008,31(7):488-491. 被引量:3
  • 7Drent M,Mulder PGH,Wagenaar S,et al.Differences in BAL fluid variables in interstitial lung diseases evaluated by discriminant analysis[J].Eur Respir J,1993,6:803-810.
  • 8Danila E,Jurgauskiene L,Norkuniene J,et al.BAL fluid cells in newly diagnosed pulmonary sarcoidosis with different clinical activity[J].Ups J Med Sci,2009,114:26-31.
  • 9Cueppens JL,Lacquet LM,Marien G,et al.Alveolar T-cell subsets in pulmonary sarcoidosis:correlation with disease activand effect of steroid treatment[J].Am Rev Respir Dis,1984,129:563-568.
  • 10Danila E,Norkūniene J,Jurgauskiene L,et al.Diagnostic role of BAL fluid CD4/CD8 ratio in different radiographic and clinical forms of pulmonary sarcoidosis[J].Clin Respir J,2009,3:214-221.

二级参考文献15

  • 1结节病诊断及治疗方案(第三次修订稿草案)[J].中华结核和呼吸杂志,1994,17(1):9-10. 被引量:149
  • 2Statement on sarcoidosis. Am J Respir Crit Care Med, 1999,160: 736-755.
  • 3Costabel U, Hunninghake GW. ATS/ERS/WASOG statement on sarcoidosis. Eur Respir J,1999,14 : 735-737.
  • 4Proceedings of the 1991 XIIth World Congress on Sarcoidosis. Kyoto, Japan, September 8-13, 1991. Sarcoidosis, 1992,9 Suppl 1:1-683.
  • 5Costabel U, Guzman J, Bronchoalveolar lavage in interstitial lung disease. Curr Opin Pulm Med, 2001,7: 255-261.
  • 6Marruchella A, Tondini M. Reliability of bronchoalveolar lavage in the routine clinical assessment of patients with sarcoidosis. A retrospective analysis. Panminerva Med, 2002,44:257-260.
  • 7Welker L, Jorres RA, Costabel U, et al. Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Eur Respir J, 2004, 24:1000-1006.
  • 8Handa T, Nagai S, Shigematsu M, et al. Patient characteristics and clinical features of Japanese sarcoidosis patients with low bronchoalveolar lavage CDJCDs ratios. Sarcoidosis Vasc Diffuse Lung Dis, 2005,22 : 154-160.
  • 9Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem, 1993,39 : 561-577.
  • 10McGrath DS, Foley PJ, Petrek M, et al. Ace gene I/D polymorphism and sarcoidosis pulmonary disease severity. Am J Respir Crit Care Med, 2001, 164:197-201.

共引文献203

同被引文献41

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部